Provider: NIHR Journals Library Content:text/plain; charset="UTF-8" TY - JOUR LB - 1. AU - Wang, NS TI - The preformed stomas connecting the pleural cavity and the lymphatics in the parietal pleura J2 - Am Rev Respir Dis PY - 1975 VL - 111 SP - 12 EP - 20 UR - https://doi.org/10.1164/arrd.1975.111.1.12 ER - TY - JOUR LB - 2. AU - Light, RW AU - Hamm, H TI - Pleural disease and acquired immune deficiency syndrome J2 - Eur Respir J PY - 1997 VL - 10 SP - 2638 EP - 2643 UR - https://doi.org/10.1183/09031936.97.10112638 ER - TY - JOUR LB - 3. AU - Grove, CS AU - Lee, YC TI - Vascular endothelial growth factor: the key mediator in pleural effusion formation J2 - Curr Opin Pulm Med PY - 2002 VL - 8 SP - 294 EP - 301 UR - https://doi.org/10.1097/00063198-200207000-00009 ER - TY - JOUR LB - 4. AU - Moldawer, LL TI - Biology of proinflammatory cytokines and their antagonists J2 - Crit Care Med PY - 1994 VL - 22 SP - S3 EP - S7 ER - TY - JOUR LB - 5. AU - Roberts, ME AU - Neville, E AU - Berrisford, RG AU - Antunes, G AU - Ali, NJ AU - BTS Pleural Disease Guideline Group TI - Management of a malignant pleural effusion: British Thoracic Society pleural disease guideline 2010 J2 - Thorax PY - 2010 VL - 65 IS - Suppl. 2 SP - ii32 EP - ii40 UR - https://doi.org/10.1136/thx.2010.136994 ER - TY - JOUR LB - 6. AU - Rodrîguez-Panadero, F AU - Borderas Naranjo, F AU - López Mejîas, J TI - Pleural metastatic tumours and effusions. Frequency and pathogenic mechanisms in a post-mortem series J2 - Eur Respir J PY - 1989 VL - 2 SP - 366 EP - 369 ER - TY - JOUR LB - 7. AU - Arnold, DT AU - De Fonseka, D AU - Perry, S AU - Morley, A AU - Harvey, JE AU - Medford, A TI - Investigating unilateral pleural effusions: the role of cytology J2 - Eur Respir J PY - 2018 VL - 52 SP - 1801254 UR - https://doi.org/10.1183/13993003.01254-2018 ER - TY - JOUR LB - 8. AU - Marel, M AU - Zrůstová, M AU - Stasný, B AU - Light, RW TI - The incidence of pleural effusion in a well-defined region. Epidemiologic study in central Bohemia J2 - Chest PY - 1993 VL - 104 SP - 1486 EP - 1489 UR - https://doi.org/10.1378/chest.104.5.1486 ER - TY - GEN LB - 9. AU - Office for National Statistics TI - Cancer Statistics Registrations, England (Series MB1), No. 44, 2013 CY - Newport PB - Office for National Statistics PY - 2015 ER - TY - JOUR LB - 10. AU - Heffner, JE AU - Nietert, PJ AU - Barbieri, C TI - Pleural fluid pH as a predictor of survival for patients with malignant pleural effusions J2 - Chest PY - 2000 VL - 117 SP - 79 EP - 86 UR - https://doi.org/10.1378/chest.117.1.79 ER - TY - JOUR LB - 11. AU - Clive, AO AU - Kahan, BC AU - Hooper, CE AU - Bhatnagar, R AU - Morley, AJ AU - Zahan-Evans, N TI - Predicting survival in malignant pleural effusion: development and validation of the LENT prognostic score J2 - Thorax PY - 2014 VL - 69 SP - 1098 EP - 1104 UR - https://doi.org/10.1136/thoraxjnl-2014-205285 ER - TY - JOUR LB - 12. AU - Psallidas, I AU - Kanellakis, NI AU - Gerry, S AU - Thézénas, ML AU - Charles, PD AU - Samsonova, A TI - Development and validation of response markers to predict survival and pleurodesis success in patients with malignant pleural effusion (PROMISE): a multicohort analysis J2 - Lancet Oncol PY - 2018 VL - 19 SP - 930 EP - 939 UR - https://doi.org/10.1016/S1470-2045(18)30294-8 ER - TY - JOUR LB - 13. AU - Pilling, JE AU - Dusmet, ME AU - Ladas, G AU - Goldstraw, P TI - Prognostic factors for survival after surgical palliation of malignant pleural effusion J2 - J Thorac Oncol PY - 2010 VL - 5 SP - 1544 EP - 1550 UR - https://doi.org/10.1097/JTO.0b013e3181e95cb8 ER - TY - JOUR LB - 14. AU - Bhatnagar, R AU - Rahman, NM TI - The palliation of malignant pleural effusions J2 - Br J Hosp Med PY - 2012 VL - 73 SP - 4 EP - 5 UR - https://doi.org/10.12968/hmed.2012.73.1.4 ER - TY - JOUR LB - 15. AU - Perricone, G AU - Mazzarelli, C TI - Images in clinical medicine. Reexpansion pulmonary edema after thoracentesis J2 - N Engl J Med PY - 2014 VL - 370 SP - e19 UR - https://doi.org/10.1056/NEJMicm1309844 ER - TY - JOUR LB - 16. AU - Bhatnagar, R AU - Keenan, EK AU - Morley, AJ AU - Kahan, BC AU - Stanton, AE AU - Haris, M TI - Outpatient talc administration by indwelling pleural catheter for malignant effusion J2 - N Engl J Med PY - 2018 VL - 378 SP - 1313 EP - 1322 UR - https://doi.org/10.1056/NEJMoa1716883 ER - TY - JOUR LB - 17. AU - Wahidi, MM AU - Reddy, C AU - Yarmus, L AU - Feller-Kopman, D AU - Musani, A AU - Shepherd, RW TI - Randomized trial of pleural fluid drainage frequency in patients with malignant pleural effusions. The ASAP Trial J2 - Am J Respir Crit Care Med PY - 2017 VL - 195 SP - 1050 EP - 1057 UR - https://doi.org/10.1164/rccm.201607-1404OC ER - TY - JOUR LB - 18. AU - Aelony, Y TI - Tunnelled pleural catheters in malignant pleural effusion - Author’s reply J2 - Lancet PY - 2007 VL - 370 SP - 387 UR - https://doi.org/https://doi.org/10.1016/S0140-6736%2807%2961190-8 ER - TY - JOUR LB - 19. AU - Villanueva, AG AU - Gray, AW AU - Shahian, DM AU - Williamson, WA AU - Beamis, JF TI - Efficacy of short term versus long term tube thoracostomy drainage before tetracycline pleurodesis in the treatment of malignant pleural effusions J2 - Thorax PY - 1994 VL - 49 SP - 23 EP - 25 UR - https://doi.org/10.1136/thx.49.1.23 ER - TY - JOUR LB - 20. AU - Davies, HE AU - Mishra, EK AU - Kahan, BC AU - Wrightson, JM AU - Stanton, AE AU - Guhan, A TI - Effect of an indwelling pleural catheter vs chest tube and talc pleurodesis for relieving dyspnea in patients with malignant pleural effusion: the TIME2 randomized controlled trial J2 - JAMA PY - 2012 VL - 307 SP - 2383 EP - 2389 UR - https://doi.org/10.1001/jama.2012.5535 ER - TY - JOUR LB - 21. AU - Clive, AO AU - Jones, HE AU - Bhatnagar, R AU - Preston, NJ AU - Maskell, N TI - Interventions for the management of malignant pleural effusions: a network meta-analysis J2 - Cochrane Database Syst Rev PY - 2016 VL - 5 UR - https://doi.org/10.1002/14651858.CD010529.pub2 ER - TY - JOUR LB - 22. AU - de Fonseka, D AU - Bhatnagar, R AU - Maskell, NA TI - Local anaesthetic (medical) thoracoscopy services in the UK J2 - Respiration PY - 2018 VL - 96 SP - 560 EP - 563 UR - https://doi.org/10.1159/000491674 ER - TY - JOUR LB - 23. AU - Yim, AP AU - Chan, AT AU - Lee, TW AU - Wan, IY AU - Ho, JK TI - Thoracoscopic talc insufflation versus talc slurry for symptomatic malignant pleural effusion J2 - Ann Thorac Surg PY - 1996 VL - 62 SP - 1655 EP - 1658 UR - https://doi.org/10.1016/S0003-4975(96)00808-9 ER - TY - JOUR LB - 24. AU - Terra, RM AU - Junqueira, JJM AU - Teixeira, LR AU - Vargas, FS AU - Pêgo-Fernandes, PM AU - Jatene, FB TI - Is full postpleurodesis lung expansion a determinant of a successful outcome after talc pleurodesis? J2 - Chest PY - 2009 VL - 136 SP - 361 EP - 368 UR - https://doi.org/10.1378/chest.08-2448 ER - TY - JOUR LB - 25. AU - Dresler, CM AU - Olak, J AU - Herndon, JE AU - Richards, WG AU - Scalzetti, E AU - Fleishman, SB TI - Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion J2 - Chest PY - 2005 VL - 127 SP - 909 EP - 915 UR - https://doi.org/10.1378/chest.127.3.909 ER - TY - JOUR LB - 26. AU - Bhatnagar, R AU - Laskawiec-Szkonter, M AU - Piotrowska, HE AU - Kahan, BC AU - Hooper, CE AU - Davies, HE TI - Evaluating the efficacy of thoracoscopy and talc poudrage versus pleurodesis using talc slurry (TAPPS trial): protocol of an open-label randomised controlled trial J2 - BMJ Open PY - 2014 VL - 4 SP - e007045 UR - https://doi.org/10.1136/bmjopen-2014-007045 ER - TY - JOUR LB - 27. AU - Ryder, H AU - Ankrom, A AU - Gocklin, P AU - Michaud, G TI - Cost effectiveness analysis of strategies for managing malignant pleural effusions J2 - Am J Respir Crit Care Med PY - 2011 VL - 183 SP - A3082 ER - TY - JOUR LB - 28. AU - Olden, AM AU - Holloway, R TI - Treatment of malignant pleural effusion: PleuRx catheter or talc pleurodesis? A cost-effectiveness analysis J2 - J Palliat Med PY - 2010 VL - 13 SP - 59 EP - 65 UR - https://doi.org/10.1089/jpm.2009.0220 ER - TY - JOUR LB - 29. AU - Puri, V AU - Pyrdeck, TL AU - Crabtree, TD AU - Kreisel, D AU - Krupnick, AS AU - Colditz, GA TI - Treatment of malignant pleural effusion: a cost-effectiveness analysis J2 - Ann Thorac Surg PY - 2012 VL - 94 SP - 374 EP - 379 UR - https://doi.org/10.1016/j.athoracsur.2012.02.100 ER - TY - ELEC LB - 30. AU - ISRCTNregistry.com TI - A Randomised Trial to Determine the Best Method for Delivering Talc for the Management of Malignant Pleural Effusions in Patients with a Good Performance Status PY - 2018 UR - www.isrctn.com/ISRCTN47845793 M1 - 21 March 2019 ER - TY - GEN LB - 31. AU - Cancer Research UK TI - A Trial Looking at How to Treat Fluid on the Lung (TAPPS) CY - London PB - Cancer Research UK PY - 2018 UR - www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-trial-looking-at-how-treat-fluid-lung-tapps Y2 - 21 March 2019 ER - TY - JOUR LB - 32. AU - White, IR AU - Horton, NJ AU - Carpenter, J AU - Pocock, SJ TI - Strategy for intention to treat analysis in randomised trials with missing outcome data J2 - BMJ PY - 2011 VL - 342 SP - d40 UR - https://doi.org/10.1136/bmj.d40 ER - TY - JOUR LB - 33. AU - Kahan, BC AU - Morris, TP TI - Improper analysis of trials randomised using stratified blocks or minimisation J2 - Stat Med PY - 2012 VL - 31 SP - 328 EP - 340 UR - https://doi.org/10.1002/sim.4431 ER - TY - JOUR LB - 34. AU - Kahan, BC AU - Morris, TP TI - Reporting and analysis of trials using stratified randomisation in leading medical journals: review and reanalysis J2 - BMJ PY - 2012 VL - 345 SP - e5840 UR - https://doi.org/10.1136/bmj.e5840 ER - TY - JOUR LB - 35. AU - Fine, JP AU - Gray, RJ TI - A Proportional hazards model for the subdistribution of a competing risk J2 - J Am Stat Assoc PY - 1999 VL - 94 SP - 496 EP - 509 UR - https://doi.org/10.1080/01621459.1999.10474144 ER - TY - JOUR LB - 36. AU - Herdman, M AU - Gudex, C AU - Lloyd, A AU - Janssen, M AU - Kind, P AU - Parkin, D TI - Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L) J2 - Qual Life Res PY - 2011 VL - 20 SP - 1727 EP - 1736 UR - https://doi.org/10.1007/s11136-011-9903-x ER - TY - JOUR LB - 37. AU - Jenkinson, C AU - Stewart-Brown, S AU - Petersen, S AU - Paice, C TI - Assessment of the SF-36 version 2 in the United Kingdom J2 - J Epidemiol Community Health PY - 1999 VL - 53 SP - 46 EP - 50 UR - https://doi.org/10.1136/jech.53.1.46 ER - TY - GEN LB - 38. AU - Department of Health and Social Care TI - NHS Reference Costs 2013 to 2014 CY - London PB - Department of Health and Social Care UR - www.gov.uk/government/publications/nhs-reference-costs-2013-to-2014 Y2 - 21 March 2019 ER - TY - GEN LB - 39. AU - Personal Social Sciences Research Unit TI - Unit Costs of Health and Social Care 2015 CY - Canterbury PB - PSSRU, University of Kent UR - www.pssru.ac.uk/project-pages/unit-costs/unit-costs-2015/ Y2 - 21 March 2019 ER - TY - GEN LB - 40. AU - Personal Social Services Research Unit TI - Unit Costs of Health and Social Care 2017 CY - Canterbury PB - PSSRU, University of Kent UR - www.pssru.ac.uk/project-pages/unit-costs/unit-costs-2017/ Y2 - 21 March 2019 ER - TY - GEN LB - 41. AU - Department of Health and Social Care TI - Health Trust Reference Costs 2016–17 CY - London PB - Department of Health and Social Care UR - https://data.gov.uk/dataset/489e83d2-7b05-41e1-b8f3-c06c1a8a9de4/health-trust-reference-costs-2016-17 Y2 - 21 March 2019 ER - TY - ELEC LB - 42. AU - National Institute for Health and Care Excellence TI - Position Statement on Use of the EQ-5D-5L Valuation Set UR - www.nice.org.uk/Media/Default/About/what-we-do/NICE-guidance/NICE-technology-appraisal-guidance/eq5d5l_nice_position_statement.pdf M1 - 21 March 2019 ER - TY - JOUR LB - 43. AU - van Hout, B AU - Janssen, MF AU - Feng, YS AU - Kohlmann, T AU - Busschbach, J AU - Golicki, D TI - Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets J2 - Value Health PY - 2012 VL - 15 SP - 708 EP - 715 UR - https://doi.org/10.1016/j.jval.2012.02.008 ER - TY - JOUR LB - 44. AU - Brazier, J AU - Roberts, J AU - Deverill, M TI - The estimation of a preference-based measure of health from the SF-36 J2 - J Health Econ PY - 2002 VL - 21 SP - 271 EP - 292 UR - https://doi.org/10.1016/S0167-6296(01)00130-8 ER - TY - GEN LB - 45. AU - Information Services Division Scotland TI - Theatres: Costs – Detailed Tables CY - Edinburgh PB - Information Services Division Scotland UR - www.isdscotland.org/Health-Topics/Finance/Costs/Detailed-Tables/Theatres.asp Y2 - 21 March 2019 ER - TY - ELEC LB - 46. AU - NHS TI - NHS Supply Chain UR - www.supplychain.nhs.uk/ M1 - 4 July 2019 ER - TY - ELEC LB - 47. AU - Joint Formulary Committee TI - British National Formulary UR - https://bnf.nice.org.uk/ M1 - 21 March 2019 ER - TY - GEN LB - 48. AU - National Institute for Health and Care Excellence TI - Guide to the Methods of Technology Appraisal 2013 CY - London PB - National Institute for Health and Care Excellence UR - www.nice.org.uk/process/pmg9/chapter/foreword Y2 - 21 March 2019 ER - TY - GEN LB - 49. AU - National Institute for Health and Care Excellence TI - Appraising Life-Extending, End of Life Treatments CY - London PB - National Institute for Health and Care Excellence PY - 2009 ER - TY - GEN LB - 50. AU - National Institute for Health and Care Excellence TI - Value Based Assessment of Health Technologies CY - London PB - National Institute for Health and Care Excellence PY - 2014 ER - TY - JOUR LB - 51. AU - Briggs, AH AU - Wonderling, DE AU - Mooney, CZ TI - Pulling cost-effectiveness analysis up by its bootstraps: a non-parametric approach to confidence interval estimation J2 - Health Econ PY - 1997 VL - 6 SP - 327 EP - 340 UR - https://doi.org/10.1002/(SICI)1099-1050(199707)6:4<327::AID-HEC282>3.0.CO;2-W ER - TY - JOUR LB - 52. AU - van Hout, BA AU - Al, MJ AU - Gordon, GS AU - Rutten, FF TI - Costs, effects and C/E-ratios alongside a clinical trial J2 - Health Econ PY - 1994 VL - 3 SP - 309 EP - 319 UR - https://doi.org/10.1002/hec.4730030505 ER - TY - JOUR LB - 53. AU - Briggs, A AU - Clark, T AU - Wolstenholme, J AU - Clarke, P TI - Missing. Presumed at random: cost-analysis of incomplete data J2 - Health Econ PY - 2003 VL - 12 SP - 377 EP - 392 UR - https://doi.org/10.1002/hec.766 ER - TY - JOUR LB - 54. AU - Rubin, DB TI - Multiple imputation after 18+ years J2 - J Am Stat Assoc PY - 1996 VL - 91 SP - 473 UR - https://doi.org/10.1080/01621459.1996.10476908 ER - TY - JOUR LB - 55. AU - Schafer, JL AU - Graham, JW TI - Missing data: our view of the state of the art J2 - Psychol Methods PY - 2002 VL - 7 SP - 147 EP - 177 UR - https://doi.org/10.1037/1082-989X.7.2.147 ER - TY - JOUR LB - 56. AU - White, IR AU - Royston, P AU - Wood, AM TI - Multiple imputation using chained equations: issues and guidance for practice J2 - Stat Med PY - 2011 VL - 30 SP - 377 EP - 399 UR - https://doi.org/10.1002/sim.4067 ER - TY - JOUR LB - 57. AU - Faria, R AU - Gomes, M AU - Epstein, D AU - White, IR TI - A guide to handling missing data in cost-effectiveness analysis conducted within randomised controlled trials J2 - PharmacoEconomics PY - 2014 VL - 32 SP - 1157 EP - 1170 UR - https://doi.org/10.1007/s40273-014-0193-3 ER -